Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001209191-16-090169

Options or other derivatives

  • Chief Business Officer acquired 163,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ravindran Sanuj K. Chief Business Officer 2016-01-04 Grant or award · Employee Stock Option (right to buy) +153,000 153,000 D
Ravindran Sanuj K. Chief Business Officer 2016-01-04 Grant or award · Employee Stock Option (right to buy) +10,750 10,750 D
Loading xslF345X03/doc4.xml…